Iovance Biotherapeutics, Inc. remains a Buy rating due to Amtagvi sales growth and label expansions. Click here to read more ...
The most visible fashion statement to emerge from this era was the players’ protest uniforms: T-shirts reading “Say Her Name” ...
NEW YORK, NY / ACCESS Newswire / October 13, 2025 / Behind every sustainability promise, there’s a question few technologies ...
StealthGas has achieved a debt-free balance sheet, posted record revenue and EBITDA last quarter, yet trades at a 65% ...
On October 13, Avtar Sehra, CEO of STBL, shared updates for his company’s plan to kick off buybacks for STBL by the end of ...
The Bio-economy Science Institute is one of the Public Research Organisations that resulted from the merger of the Crown ...
A telehealth startup called Marble Health is betting on something refreshingly human: real therapists, not AI, can help solve ...